
Location: Geneva,None,None
Medicines for Malaria Venture (MMV) is the world’s leading product development partnership (PDP) dedicated to discovering, developing, and delivering affordable and effective antimalarial drugs.
MMV collaborates with government agencies, private and public sector partners, and clinical centers in malaria-endemic regions to bring lifesaving solutions to the people most affected by malaria. Our work is made possible through funding from various sources, including government agencies, foundations, corporations, and individuals.
In the context of a succession plan for our Medical Team, we are seeking a medical doctor with a specific scientific mindset to act as a key strategic partner, contributing expert insight to portfolio decisions and ensuring robust translation of preclinical and translational data into high‑quality clinical development plans. The role represents MMV as a senior scientific expert with external partners and regulators to advance MMV’s mission to deliver impactful malaria therapies. The function will report to the VP Clinical Development and Chief Medical Officer. We would equally accept to train an enthusiastic and motivated less experienced Physician into this role over a 2-year period
The (Senior) Medical Director will provide scientific and strategic leadership with a particular focus on early‑phase clinical development activities within MMV’s antimalarial portfolio. The role is accountable for shaping and delivering Phase I and early Phase II clinical development strategies, including first‑in‑human, malaria volunteer infection studies (VIS), experimental medicine, and clinical pharmacology programmes, ensuring scientific rigor, patient safety, and regulatory compliance. An understanding of drug metabolism and pharmacokinetics is desirable.
Technical Skills
Behavioural Skills
Location: Geneva, Switzerland (ideally). MMV is open to consider candidates who might be located abroad
Starting date: From 01st March 2027 or according to availability
Interested applicants should send their CV and a motivation letter explaining their interest in the position by 15th December 2026. MMV retains the right to extend or reduce the advert deadline based on number of applicants
MMV is committed to building a talented and diverse workforce, selecting candidates based on their skills, abilities, and experience. We foster an inclusive workplace, free from discrimination on the basis of race, color, religion, political beliefs, age, nationality, disability, gender, or sexual orientation.
MMV strongly encourages applications from persons with disabilities. We are committed to an inclusive recruitment process and workplace and will make reasonable adjustments where needed in addition to the accessibility measures, equipment, infrastructure, and support already available to employees. We believe that diverse perspectives strengthen our work and increase our impact.
Our hybrid working model encourages in-office collaboration. For candidates residing in Switzerland, we expect a minimum of two days per week in the office; for cross-border candidates residing in France, at least three days per week.
For more information about MMV’s activities please refer to our website www.mmv.org.
Non-mandated recruitment agencies are kindly requested to refrain from submitting applications.

MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development.
Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease.
Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries.
www.mmv.org
www.facebook.com/medicinesformalaria
www.twitter.com/medsformalaria
www.youtube.com/user/MMVmeds4malaria
http://plus.google.com/+mmvorgmedsformalaria